Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection by Major, A
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Exposure of cats to low doses of FeLV: seroconversion as the
sole parameter of infection
Major, A
Major, A. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection. 2009,
University of Zurich, Vetsuisse Faculty.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Vetsuisse Faculty, 2009.
Major, A. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection. 2009,
University of Zurich, Vetsuisse Faculty.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Vetsuisse Faculty, 2009.
Exposure of cats to low doses of FeLV: seroconversion as the
sole parameter of infection
Abstract
In felids, Feline Leukemia Virus (FeLV) infection results in a variety of outcomes that range from
abortive to progressive infection. Recently, a novel outcome was postulated for low FeLV infectious
doses. Naïve cats exposed to faeces of persistently infected cats seroconverted, indicating infection, but
remained negative for provirus and p27 antigen in blood. FeLV provirus was found in some tissues but
not in the bone marrow, infection of which is usually considered a necessary stage for disease
progression. To investigate the impact of low FeLV doses on young cats and to test our hypothesis that
low dose exposure may lead to an unknown pathogenesis of infection without involvement of the bone
marrow, 21 cats were infected oronasally with variable viral doses. Blood p27, proviral and viral loads
were followed until week 20 post-infection. Tissue proviral loads were determined as well. The immune
response was monitored by FeLV whole virus and p45 ELISA, FOCMA assay and Western blot. One
cat showed regressive infection. In 7 cats, FOCMA assay positivity was the only sign of infection.
Provirus was only found in some organs of the regressively infected cat. Here, we show that FeLV low
dose exposure can result in seroconversion during a presumed abortive infection. Therefore, commonly
used detection methods do not cover the whole spectrum of FeLV pathogenesis, leading to a possible
underestimation of the effective occurrence of infection in the cat population
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ABSTRACT 
 
 
In felids, Feline Leukemia Virus (FeLV) infection results in a variety of outcomes that 
range from abortive to progressive infection. Recently, a novel outcome was 
postulated for low FeLV infectious doses. Naïve cats exposed to faeces of 
persistently infected cats seroconverted, indicating infection, but remained negative 
for provirus and p27 antigen in blood. FeLV provirus was found in some tissues but 
not in the bone marrow, infection of which is usually considered a necessary stage 
for disease progression. To investigate the impact of low FeLV doses on young cats 
and to test our hypothesis that low dose exposure may lead to an unknown 
pathogenesis of infection without involvement of the bone marrow, 21 cats were 
infected oronasally with variable viral doses. Blood p27, proviral and viral loads were 
followed until week 20 post-infection. Tissue proviral loads were determined as well. 
The immune response was monitored by FeLV whole virus and p45 ELISA, FOCMA 
assay and Western blot. One cat showed regressive infection.  In 7 cats, FOCMA 
assay positivity was the only sign of infection. Provirus was only found in some 
organs of the regressively infected cat. Here, we show that FeLV low dose exposure 
can result in seroconversion during a presumed abortive infection. Therefore, 
commonly used detection methods do not cover the whole spectrum of FeLV 
pathogenesis, leading to a possible underestimation of the effective occurrence of 
infection in the cat population. 
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1 INTRODUCTION 
 
Feline Leukemia virus is a retrovirus of great veterinary importance. It was 
discovered more than 40 years ago [1]. FeLV infects domestic cats and some related 
small felids worldwide [2, 3]. An infection with FeLV may cause blood disorders, a 
state of immunodeficiency and fatal neoplasia. Common symptoms are fever, 
anaemia, anorexia, weight loss, vomitus and diarrhoea. 
The prevalence of FeLV infection has been decreasing in the past few years. 
In Switzerland, FeLV prevalence was found to be 3% in healthy and of up to 13% in 
ill cats [4]. Decreasing prevalence is the consequence of identification and 
segregation of infected cats, and of extensive vaccination programs. However, cases 
of recurrence keep occurring and emphasise the importance of an accurate 
diagnosis. 
FeLV is mainly transmitted directly from cat to cat. Transmission occurs 
through contact with saliva via licking, mutual grooming and sharing of food or water 
dishes or trough bites [5, 6]. Infectious FeLV can also be transmitted via faeces and 
milk [7, 8]. FeLV RNA was also detected in urine, but, its infection potential has not 
been demonstrated so far [9]. Pathogenesis is well understood if infectious pressure 
is high. Infection starts in the oropharynx where the virus first replicates in tonsils and 
local lymph nodes [10], from which  the virus spreads to the bone marrow, thymus, 
spleen and intestine through infected lymphocytes. Bone marrow infection is an 
important hallmark of FeLV pathogenesis as the virus replicates extensively in the 
bone marrow and infects blood precursor cells. Once the bone marrow is infected, 
viremia develops and many organs and tissues are affected, including salivary gland, 
tonsils, pharyngeal, urinary bladder, gastric, intestinal, colonic, pancreatic and 
endometrial epithelia, lymph nodes throughout the body, bone marrow, and spleen 
[10, 11]. 
FeLV infection presents a variety of outcomes [2, 10, 12-18], which are 
influenced by both host and virus factors. Known host resistance factors include age 
and immune system status. Known virologic factors are virus strain, subtype and viral 
infection dose [2].  
The outcome of infection is still somewhat a controversial issue. In the past,  
infection outcome was classified as viremic, non-viremic, and transient viremic based 
on results of virus isolation, immunofluorescence assays and/or antigen detection  
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[16]. Viremic cats are characterized by continuous expression of p27 viral antigen. 
FeLV infection is not contained due to a lack of FeLV specific immunity [2, 19, 20].  
Viremic cats continuously shed virus, thereby posing a risk of infection to susceptible 
cats, and usually succumb to FeLV-associated diseases (anaemia, 
immunosuppression, neoplasia). In transiently viremic cats, viremia is overcome after 
a few weeks post infection. However, transiently viremic cats remain provirus 
positive. In addition, some non-viremic cats were shown to have localized infection 
characterized by virus replication in certain tissues, such as mammary, salivary and 
urinary epithelium [7, 8, 21]. This additional form of FeLV infection was termed 
atypical or sequestered infection. New sensitive molecular assays have been 
described recently for the use in detection and quantification of FeLV provirus DNA 
and viral RNA [22-24], resulting in a more sensitive measure for FeLV exposure. The 
spectrum of host response categories was refined accordingly. Especially in p27 
negative cats, the outcome should be re-evaluated based on the presence or 
absence of FeLV proviral DNA in blood or bone marrow. The spectrum of host 
response categories was thus reclassified into: abortive (no virus detected after 
exposure), regressive (p27-negative, provirus positive after or without transient 
antigenemia) and progressive (persistently p27 positive, virus isolation, provirus 
positive, FeLV RNA positive) [18]. Whether cats that show no signs of infection 
(abortive) are truly immune or just resistant, is still open to debate.  
 In this context, a very interesting finding was that FeLV infection can be 
transmitted exclusively by contact with faeces [7] with no apparent viremia and 
infection involving the bone marrow, and constant negativity for proviral DNA in blood 
– which would be classified as abortive infection. However, in the study of Gomes et 
al. FeLV provirus could be detected in several organs and the cats showed 
seroconversion, indicating that infection indeed had occurred. It was concluded that 
under low infectious pressure a different pathogenesis may take place in which bone 
marrow is not involved. 
Since FeLV transmission at very low infection levels appears to be the most 
natural way of infection, many cats may show this yet uncharacterized outcome. Cats 
that test negative for FeLV by conventional diagnostic methods could still have been 
infected and constitute a relevant portion of the cat population affected by the virus.  
The prevalence of FeLV infection may therefore have been underestimated, a factor 
that may have important consequences for FeLV control management – notably in 
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Iberian lynxes, which seem to be particularly susceptible for FeLV infection [25] and 
for which a correct estimation of FeLV spreading potential is of great importance. 
It was thus the aim of this study to further characterize the course of infection 
after exposure to low infectious pressure and to test the hypothesis that low FeLV 
doses applied to young cats may lead to seroconversion also when the infection 
does not progress through bone marrow. The virus may not be completely eliminated 
and a limited viral replication in tissues may lead to a development of a weak immune 
response. We exposed each of three groups of 7 cats to different, low doses of 
FeLV. Blood p27 antigen, proviral DNA and viral RNA were measured in blood at 
regular intervals until week 20 post infection and in popliteal and mesenteric lymph 
nodes, bone marrow, spleen, kidney, urinary bladder, lungs, thymus, myocardium, 
parotid gland, and pancreas after euthanasia. Immune response against FeLV was 
assessed by the detection of antibodies by ELISA to FeLV whole virus and to FeLV 
p45 (the recombinant env-gene product), by immunofluorescence assay to feline 
oncornavirus-associated cell membrane antigen (FOCMA), and by Western blot 
analysis to the separated FeLV components. 
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2 MATERIAL AND METHODS 
  
2.1 Animals 
Twenty-six, 9 weeks-old Specific Pathogen-Free (SPF) male kittens were 
obtained from Liberty Research, Inc. (Waverly, NY, USA). Animals were kept under 
barrier conditions and optimal ethological and hygienic conditions in one group of 5 
cats (uninfected control group) and three groups of 7 cats each (group 1K, 10K, and 
100K, based on viral infectious dose). Prior to the beginning of the experiment the 
cats were tested by PCR, RT-PCR and serology and shown to be negative for FeLV, 
FIV, Herpes-, Corona-, Calici-, Parvovirus and feline hemotropic mycoplasmas. 
 
2.2 FeLV-A virus challenge 
At the age of 16 weeks, each kitten of groups 1K, 10K, and 100K were 
infected once oronasally with FeLV-A/Glasgow-1 [26] by introducing 0.2ml of virus 
suspension into each nostril and 0.6ml into the mouth. The virus suspension for 
group 1K contained a total of 1’000 focus-forming units (FFU), the one for group 10K 
10’000 FFUs and group 100K 100’0000 FFUs. The viral stock origin and infectivity 
was the same as described in earlier works [27, 28]. 
 
2.3 Sample collection and processing 
Blood samples were collected under sedation (0.1mg/kg midazolam 
(Dormicum®, Roche Pharma AG, Reinach, Switzerland) and 10mg/kg ketamine 
(Narketan®, Vétoqinol AG, Belp, Switzerland) prior to challenge at week -7, -5, -3, 
and then weekly, starting from week 0 until week 6 post-infection (p.i.), later in 
biweekly intervals until week 20 p.i. Blood samples were obtained by jugular 
venipuncture using 5ml syringes and blood was immediately transferred into EDTA-
tubes.  
400µl of EDTA blood was submitted for haematology analysis, 200µl of EDTA 
anticoagulated whole blood were aliquoted for DNA extraction. 
Plasma was obtained by centrifuging approximately 2ml of EDTA blood at 
1700g for 10 minutes. Blood and plasma samples were immediately frozen at -80 °C 
until they were processed. 
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2.4 Detection of proviral DNA and plasma viral RNA 
For determination of FeLV proviral loads, total nucleic acids were extracted 
from a blood volume containing 106 white blood cells using the MagNa Pure LC Total 
Nucleid Acid Isolation Kit (Roche diagnostics AG, Rotkreuz, Switzerland). The 
extracted total nucleic acids were analyzed by real-time TaqMan PCR as described 
[24] on a ABI 7500 sequence detection system (Applied Biosystems, Foster City, CA, 
USA). 
For each run, a glyceraldehyde-3-phophate dehydrogenase (GAPDH) 
pseudogene of which one copy is present in the genomic DNA of feline cells [29] was 
also quantified. FeLV proviral DNA amounts were normalized to feline GAPDH by 
dividing FeLV copy numbers by fGAPDH copy numbers to calculate FeLV copies per 
cell. 
Viral RNA in plasma samples was extracted from 200µl of plasma (either from 
5-sample pools or from single samples) using the MagNa Pure LC Total Nucleic 
Isolation Kit and quantified by real-time TaqMan reverse transcriptase (RT)-PCR as 
described [24].  
 
2. Detection of FeLV virus protein p27 by ELISA 
The presence of plasma FeLV p27 antigen was determined using a sandwich 
ELISA as previously described [30]. Results are represented as percentages of a 
defined positive control (culture supernatant of FL-74 feline lymphoblastoid cell line 
permanently expressing FeLV), which was considered 100%. Samples reaching > 
5% of the positive control signal were considered positive. 
 
2.6 Antibody assays 
The plasma samples were also analysed for the presence of antibodies to 
FeLV whole virus, to FeLV p45 (the non-glycolsylated form of gp70 surface unit of 
the envelope glycoprotein), and to FOCMA. 
 
2.6.1 FeLV p45 and whole virus ELISAs 
Anti-FeLV p45 and anti-FeLV whole virus antibodies were measured by ELISA 
as described [15, 31], using 100ng of p45/well and 100ng of gradient purified FL-74 
FeLV, respectively. Plasma was used at a dilution of 1:200. 
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2.6.2 FL-74 cell membrane immunofluorescence assay 
Antibody to FOCMA was measured at week 0 and week 20 p.i., by indirect cell 
membrane immunofluorescence as described [32]. FL-74 cell culture medium was 
tested for the absence of FCV, FHV, FPV, FCoV, FIV, hemotropic mycoplasma and 
presence of FeLV by RT-PCR/PCR as described [24, 33-38]. The culture was 
consistently free of the unwanted contaminants. The cat sera were titrated at 4-fold 
dilutions from 1:4 to 1:256. The antibody titre was taken as the reciprocal of the 
highest dilution of serum producing bright ring fluorescence.  
  
2.6.3 Western blot analysis 
In addition, samples from week -3 and week 20 p.i. were examined for the 
presence of antibodies to FeLV gp70, p27 and p15(E) [30, 39] by Western blot 
analysis as described [40].  
 
2.7 Detection of FeLV provirus and virus isolation from tissues and bone 
marrow  
Cats of group 10K and group 100K were euthanized in week 20, and tissue 
samples from popliteal and mesenteric lymph nodes, bone marrow, spleen, kidney, 
urinary bladder, lungs, thymus, myocardium, parotid gland, and pancreas were 
collected within 30 min post-mortem. Samples were immediately snap-frozen in liquid 
nitrogen. 10mg of tissue were used for the extraction of DNA using MagNA Pure LC 
DNA Isolation Kit II [Tissue] (Roche Diagnostics, Mannheim, Germany). FeLV 
provirus was quantified by real-time PCR as described above [24, 41]. To guarantee 
a comparable sensitivity, samples yielding less than 15’000 fGAPDH copies per 
reaction were re-extracted until a suitable concentration was reached. 
In addition, we collected samples under sterile conditions from mesenteric 
lymph node, urinary bladder, lungs, thymus, and myocardium for virus isolation. 
Tissue samples were co-cultured with FEA cells and supernatants of the co-cultures 
collected at days 4, 8, 12, 16, 20, 24, and 28 post-inoculation were tested for p27 
antigen by ELISA as described [42].  
Bone marrow samples were cultured in medium and supernatants collected at 
days 18 and 21 were used for total nucleic acid isolation (MagNA Pure LC Total  
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Nucleic Acid Isolation Kit, Roche Diagnostics) and samples were tested for the 
presence of FeLV RNA. Additionally, supernatants were tested by p27 ELISA [30]. 
 
2.8 Statistical analysis 
Statistical analyses were carried out using R software version 2.9.0. (The R 
Foundation for Statistical Computing, Vienna, Austria). Longitudinal effects (time) on 
antibody titres of the different groups were compared to each other by multivariate 
analysis if variance (MANOVA). A p-value <0.05 was considered to be statistically 
significant. 
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3 RESULTS 
 
3.1 FeLV DNA and RNA detection in blood 
With one exception, cats did not become provirus positive at any time point 
tested. The one cat (JCR2) that was found to be positive belonged to the group 
challenged with the highest of the three doses of FeLV (100’000 FFUs). Proviral DNA 
was detected from week 2 p.i. on with a peak at week 3 (3.33 copies/cell) (Figure 1).  
Similarly, viral RNA was consistently detected only in samples of the provirus-
positive cat (JCR2) until week 12 and additionally at week 18 once more. The highest 
viral RNA load measured was at week 2 p.i. (Ct-value of 22.95, Figure 1). We were 
not able to detect viral RNA in pooled plasma samples (5 samples each pool) of any 
of the provirus-negative cats at week 0, 10, and 20 p.i.. In addition, samples from 
week 2, 3, and 4 were tested individually, as the viral RNA peak usually occurs in this 
time period; the results were negative, too.  
 
3.2 Detection of p27 in plasma 
P27 antigen was detected in plasma of one (JCR2) of the 26 cats tested. This 
cat became transiently positive at week 3 p.i. and week 4 p.i. (Figure 1). We were not 
able to detect p27 at any time point in all other cats.  
 
3.3 Antibody assays 
 
3.3.1 FeLV p45 and whole virus ELISAs 
By measuring antibodies against FeLV p45 and whole virus by ELISA, 
seroconversion was observed in one cat. In the p45 ELISA, this cat (JCR2) had a 
positive response throughout weeks 8 to 20 with a peak of 26% of the positive control 
at week 14, and throughout weeks 4 to 20 with a peak of 54% of the positive control 
at week 20 in the FeLV whole virus ELISA (data not shown). Analysis of the 
remaining animals showed no statistically relevant difference between the groups in 
p45 as well as whole virus ELISA (PMANOVA 0.53 and 0.47, respectively. Figure 2 and 
3).  
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Figure 1. Proviral DNA, viral RNA, and plasma p27 loads from the persistent PCR-positive cat JCR2 
measured at regular intervals until week 20 p.i. 
Provirus loads are expressed as cycle threshold (Ct) value 45 (considered to be negative) minus Ct 
values measured. p27 antigen ELISA values are represented as percentage in comparison to a 
positive control (FL-74 lymphoblastoid cell culture supernatant), which was considered to be 100%. 
The cat JCR2 found to be consistently provirus positive, showed a regressive infection with transient 
antigenemia. 
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Figure 2. Box-plot results obtained measuring antibodies directed to FeLV p45 over the whole 
observation period as percentage of the positive control. The PCR-positive cat of group 100K was 
excluded. No statistically relevant difference between the groups was observed. Open boxes: negative 
controls, crossed boxes: 1K group, dotted boxes: 10K group, hatched boxes: 100K group. Outliers are 
depicted by a dot. 
 
 
 
Figure 3. Antibodies directed to FeLV whole virus. Results are expressed as percentage of a positive 
control. The PCR-positive cat of group 100K was excluded. No statistically relevant difference 
between the groups was observed. Open boxes: negative controls, crossed boxes: 1K group, dotted 
boxes: 10K group, hatched boxes: 100K group. Outliers are depicted by a dot. 
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3.3.2 FL-74 cell membrane immunofluorescence assay 
Prior to challenge, all samples were negative for the presence of antibodies 
directed against FOCMA. At week 20 p.i., antibodies to FOCMA were detected in 4 
cats (KCT1, JCU3, JCO2, JCP1, 57%) of group 10K and 4 (KDA1, JCR2, KCQ1, 
JCS1, 57%) cats of group 100K. Of these 8 cats, the PCR-positive cat (JCR2) 
reached the highest titre (64), the other 7 cats developed antibody titres which 
ranged from 1 to 16. No negative control group and group 1K animal had a 
detectable titre (Table 1).  
 
 
TABLE 1. Titres of antibodies detected by indirect FL-74 FOCMA 
immunofluorescence test pre- and post exposure to low FeLV doses.  
 
  neg. control   group 1K   group 10K   group 100K 
titre week 0 week 20   week 0 week 20   week 0 week 20   week 0 week 20 
neg   7 a 7  7 7  7 3  7 3 
4 0 0  0 0  0 2  0 3 
16 0 0  0 0  0 2  0 0 
64 0 0  0 0  0 0  0 1 
                        
a Numbers represent the total number of cats with a certain titer 
 
 
3.3.3 Western blot analysis 
In Western blot analysis, sera from two cats of group 10K (JCU3, JCS2) 
showed a weak reactivity to the upper band of the p15(E) protein at a serum dilution 
of 1:40 as well as at 1:100. One cat of group 100K (KDA1) showed a weak reactivity 
to the p58 protein. However, cat JCU3 showed some reactivity to the upper band of 
p15(E) and cat KDA1 to the band of p58, respectively, already at week 0 p.i. (Figure 
4). In the PCR-positive cat (JCR2) the presence of antibodies against FeLV was 
confirmed at a dilution of 1:100. All other cats had completely negative Western blot 
pattern (Figure 4).  
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Figure 4. Western blot analysis using plasma samples from week -3 (prior to challenge) and week 20 
p.i. (cats group 100K and two of group 10K) 
The first 3 strips to the left were incubated with monoclonal antibodies against gp70, p27 and p15(E), 
respectively, to characterize the respective viral proteins. 
Serum obtained from a pool of immune cats used as a positive control. Cat JCU3 and cat JCS2 (group 
10K) show a weak reaction with the upper band of the p15(E) protein. Cat KDA1 (group 100K) shows 
a weak reactivity to the band of the p58 protein. JCR2 shows antibodies to all FeLV proteins. In all 
other cats, responses to any FeLV proteins could not be detected. (►) bands with expected length. All 
samples were tested under the same assay conditions. 
 
 
3.4 Detection of FeLV DNA sequences and virus isolation from tissues 
At week 20 post-challenge, cats of groups 10K and 100K were euthanized and 
different tissue samples were collected and analysed for the presence of FeLV DNA 
sequences. Popliteal and mesenteric lymph nodes, bone marrow, spleen, kidney, 
urinary bladder, lungs, thymus, myocardium, parotid gland, and pancreas were 
tested. 
FeLV DNA sequences were found in organs of the cat (JCR2) positive for 
FeLV provirus in blood. The copy numbers were in average very low and ranged 
from 5.6 to 704.25 copies/reaction (3.4x10-5 to 0.0024 copies/cell, data not shown).  
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The popliteal lymph node showed the highest FeLV proviral load (0.0024 copies/cell). 
No FeLV DNA sequences were detected in tissue samples of all other cats. 
Virus isolation from urinary bladder, myocardium, lungs, mesenteric lymph 
node, thymus, and bone marrow was negative for all cats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Discussion 
  17
4 DISCUSSION 
 
The aim of this study was to investigate to what degree cats can become 
infected by low-dose oral FeLV infection without detectable involvement of the bone 
marrow. 
Even though FeLV prevalence has reportedly decreased during the past 
years, it is still among the most important infectious diseases of cats. Hence, a deep 
knowledge of all aspects of FeLV pathogenesis and biology is essential. Recently, a 
novel course of infection was postulated that deviates from the classical course 
involving a phase in which bone marrow is infected. In this alternative course, cats 
exposed to low loads of virus via faecal route seroconverted without involvement of 
bone marrow and without showing any other sign of infection [7]. Under field 
conditions, exposure to small virus loads is expected to be frequent due to superficial 
direct contact with viremic cats shedding FeLV or indirectly through contact with 
excretions produced by viremic cats. Thus, many cats may show this newly 
recognized outcome. Since experimental infection had to mimic the natural mode of 
transmission trough faeces or saliva, in the present study we challenged the cats 
oronasally with viral loads that, based on published results [43] and on our 
experience, would induce abortive or regressive infection. Indeed, only one cat 
belonging to the group with the highest challenge dose showed regressive infection. 
For all other cats, abortive infection would have been assigned based on commonly 
used methods [18]. 
In this study, we demonstrated that a single oronasal exposure to FeLV as low 
as 10’000 FFU is sufficient to elicit an antibody response and to lead to 
seroconversion in at least 18% (lower 95% confidence interval of the distribution) of 
the cats, demonstrating that the postulated alternative course of infection may occur 
in a considerable portion of the animals. We propose to designate this outcome of 
infection as abortive infection with seroconversion. No hallmark of infection was 
observed in the cats that received the smallest of the three doses (1’000 FFU), for 
which individual local innate immunity might have been enough to contain viral 
replication and to lead to abortive infection without a detectable adaptive immune 
response. However, under field conditions, multiple exposures in the range of 1’000 
FFUs or lower may occur giving rise to seroconversion or even provirus positivity. 
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Considering that our assay for proviral DNA is able to detect one copy per 
reaction, we believe that the consistent PCR-negativity in blood of the cats that 
seroconverted is a strong indicator for the absence of bone marrow infection, a 
confirmation that an alternative course of infection may indeed exist, where the bone 
marrow is not involved. FeLV provirus may still be integrated into the genome of the 
cells of some tissues but, in most cases, at levels beyond detection. In our study, we 
were not able to detect any FeLV DNA sequences in the organs tested. However, the 
presence of FeLV provirus in tissues other than the ones we analysed can not be 
excluded and should be investigated further. In localized infection where FeLV 
replication is confined to certain tissues, presence of plasma viral RNA loads is 
regarded a sensitive parameter for infection. RNA loads reflect ongoing viral 
replication somewhere in the cat’s body even in sequestered places. However, 
detection of RNA is generally less frequent than that of proviral DNA [24].  
Seroconversion was observed by use of the FL-74 cell membrane 
immunofluorescence test. This assay originally had been designated FOCMA test 
and was thought to detect antibodies at a non-virion tumour-associated antigen [32]. 
Later, it became clear that the FOCMA phenomenon can be explained not by a 
tumour specific antigen but by viral proteins including FeLV p15(E), gag-polyproteins 
and gp70 of FeLV subtype C present on the FL-74 cell membrane [44]. The FL-74 
cell membrane immunofluorescence test seems to be the most sensitive method to 
detect seroconversion compared to ELISA and Western blotting. This may be due in 
part to the less stringent test conditions, which allow antibodies with lower affinity to 
bind to their epitopes, and in part to the fact that in the FOCMA assay the binding 
targets are presented in a native-like conformation, thus allowing a better binding of 
conformation-depending specific antibodies.  
We did not test whether the oral low-dose infection did induce cytotoxic T-cells 
or virus-neutralizing antibodies, nor did we measure Th-1 cytokine expression that 
might have been induced by the experimental infection. We concentrated on the 
detection of antibodies as they can serve as markers of infection. 
It is unclear to what degree the alternative pathway may be relevant to the 
spread of FeLV infection. We speculate that in most cases cats will overcome the 
infection for good. In very few cases - when the infected cats undergoes 
immunosuppression due e.g. to concomitant FIV infection - full-blown FeLV infection  
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with bone marrow involvement and viral shedding may develop. It will be important to 
determine to what extent this may occur. 
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5 CONCLUSION 
 
The present extends the evidence for existence of an alternative FeLV 
infection course that leads to seroconversion without involvement of the bone marrow 
phase. The results may be important for the surveillance of the FeLV status of a 
cattery or a cat population. Most likely a cattery cannot be considered free of FeLV 
as long as cats with seroconversion are present. The potential for overt infection 
cannot be neglected. 
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